Eli Lilly reported higher profit and raised its outlook on surging demand for its weight-loss drugs, sending its shares ...

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and spawning a ...

Eli Lilly (LLY) is one of Nvidia's (NVDA) many partners announced by the artificial intelligence (AI) chipmaker. The two ...

Eli Lilly's experimental weight-loss pill, orforglipron, has met key FDA criteria for an expedited review, boosting its ...

Tech shares have risen sharply on optimism over AI's potential and a series of partnerships and deals with major global ...

Current health news highlights include Calley Means' departure from the White House, Cipla CEO Umang Vohra's upcoming resignation, a U.S. government shutdown threatening food aid, Eli Lilly's and Novo ...

Eli Lilly shares surged after strong third-quarter results and a raised annual forecast, powered by booming demand for its ...

Both sales figures came in well ahead of analyst expectations and will heap pressure on Lilly's main rival in the GLP-1 ...

Nvidia has become the first company in history to surpass a $5 trillion market capitalization. This marks another milestone ...

What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.1% in the morning session after the ...

Alphabet (NASDAQ:GOOGL) stock gained 7.5% after the Google parent’s third-quarter revenue reached a record high, while net ...

The drugmaker posted revenue of $17.6 billion in the period, which also topped Street forecasts. Six analysts surveyed by Zacks expected $16.01 billion. Lilly expects full-year earnings in the range ...